Company Monitoring Page for biotech

latest headlines for company on cafepharma

Whether it’s Trump or Clinton, biotech is in for ‘a moment of change’
Stat
Fri, 10/7/16 - 09:05 am
Tags:
biotech, Donald Trump, Hillary Clinton, 2016 Presidential election, drug pricing
These 2 Biotechs Could Vanish by 2018
Motley Fool
Fri, 10/7/16 - 08:57 am
Tags:
biotech, Acadia, MannKind, Nuplazid, Afrezza
Two Big Biotechs Flash Bearish Signals
Investopedia
Sun, 10/2/16 - 10:13 am
Tags:
biotech, Celgene, Gilead Sciences
Biotech IPOs: Outliers, Value Creation And The Dispersion Of Returns
Forbes
Tue, 09/27/16 - 10:15 am
Tags:
biotech, IPOs
3 Biotechs That Could Be M&A Targets
Motley Fool
Sat, 09/24/16 - 01:40 pm
Tags:
biotech, M&A, cancer, Seattle Genetics, Array Biopharma, Clovis Oncology
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Motley Fool
Wed, 09/21/16 - 10:59 pm
Tags:
biotech, FDA, Aerie Pharma, Rhopressa, Flexion, Zilretta, Puma Biotechnology, neratinib
So Takeda wants to do up to $20B in M&A? Welcome to the bidding war for US biotechs
Endpoints
Wed, 09/14/16 - 09:12 am
Tags:
M&A, Takeda, biotech
Potential Silver Lining Of Pharma Price Pressure: More Biotech Deal-making?
Forbes
Wed, 09/14/16 - 09:11 am
Tags:
drug pricing, biotech
Biotech CEOs: Don't Let EpiPen Threaten Innovation
Forbes
Tue, 09/13/16 - 10:29 am
Tags:
biotech, CEOs, innovation, Mylan Labs, EpiPen
Biotech on track for best day since June
CNBC
Mon, 09/12/16 - 05:14 pm
Tags:
biotech
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
Tags:
biotech, Eli Lilly, solanezumab, Biogen, aducanumab, Kite Pharma, KTE-C19, Bluebird Bio, LentiGlobin, Sarepta Therapeutics, eteplirsen, Ophthotech, Fovista, Bristol-Myers Squibb, Opdvio, Acadia, Nuplazid, Celgene, GED-301, Gilead Sciences, M&A
3 Hottest Cancer Biotech Acquisition Targets After Medivation
Forbes
Tue, 09/6/16 - 11:11 pm
Tags:
cancer, biotech, M&A, Puma Biotechnology, Jazz Pharmaceuticals, Kite Pharma
3 Biotech Stocks Could Be the Next Big Takeover Targets
24/7 Wall St
Wed, 08/31/16 - 09:20 am
Tags:
biotech, M&A, Biomarin, Incyte, Tesaro
4 Biotech Buyout Targets for Gilead, Sanofi After Medivation Miss
Barron's
Tue, 08/23/16 - 11:11 am
Tags:
biotech, M&A, Gilead Sciences, Sanofi, Medivation, Incyte, Biomarin, Tesaro, Seattle Genetics
Google’s Krishna Yeshwant wants to back the next big new idea in biotech
Endpoints
Tue, 08/23/16 - 09:58 am
Tags:
Google, biotech, 47, Calico, start-ups
Pfizer's Medivation buy seen prescribing more biotech M&A
Yahoo/Reuters
Mon, 08/22/16 - 10:30 pm
Tags:
Pfizer, Medivation, M&A, biotech, Vertex Pharmaceuticals, Alexion, Neurocrine, Intercept Pharma
Chinese development group blueprints $1B-plus biotech campus in South San Francisco
Endpoints
Fri, 08/19/16 - 11:43 am
Tags:
biotech, China, San Francisco
How to fail well in biotech: shed a tear, grab a trophy, and move on
Stat
Wed, 08/17/16 - 10:58 am
Tags:
Biogen, Lou Gehrig's disease, biotech, failure
Biotech CEO confidence returns, but deal landscape still seen as bleak
Fierce Biotech
Tue, 08/16/16 - 04:38 pm
Tags:
biotech
Will some pent-up deal pressure amp up a biotech rally?
Endpoints
Mon, 08/15/16 - 09:42 pm
Tags:
biotech, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.